Status:
COMPLETED
Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management
Lead Sponsor:
Klein Buendel, Inc.
Collaborating Sponsors:
HPC International, Inc.
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
13+ years
Phase:
NA
Brief Summary
Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet assessments to identify type, intensity, frequency, and phase of pain among SCD adolescents is lacking. Re...
Detailed Description
Sickle cell disease (SCD) is the most common inherited blood disorder in the U.S. and disproportionately affects African Americans and Hispanics. Approximately, 1,000 U.S. children are born with SCD a...
Eligibility Criteria
Inclusion
- Phone Interview, Focus Group, and Usability
- Be 13-17 years of age
- Be diagnosed with Sickle Cell Disease
- Able to read and speak English
- Able to assent to participate
- Phone Interview, Focus Group, and Usability
Exclusion
- Not 13-17 years of age
- Not diagnosed with Sickle Cell Disease
- Unable to read and speak English
- Unable to assent to participate
- Healthcare Provider Interview Inclusion Criteria:
- Be a healthcare provider to teens with sickle cell disease
- Be 18 years of age or older
- Able to read and speak English
- Able to consent to participate
- Healthcare Provider Interview
Key Trial Info
Start Date :
January 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2017
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03291613
Start Date
January 15 2017
End Date
September 30 2017
Last Update
February 6 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Klein Buendel, Inc.
Golden, Colorado, United States, 80401
2
Hilton Publishing Company
Munster, Indiana, United States, 463213963